| Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study C Erem, A Hacihasanoglu, M Kocak, O Deger, M Topbas Journal of public health 31 (1), 47-58, 2009 | 385 | 2009 |
| Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study C Erem, A Hacihasanoglu, O Deger, M Kocak, M Topbas Endocrine 34, 36-51, 2008 | 198 | 2008 |
| The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus E Fidan, H Onder Ersoz, M Yilmaz, H Yilmaz, M Kocak, C Karahan, ... Acta diabetologica 48, 297-302, 2011 | 133 | 2011 |
| Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged … C Erem, I Nuhoglu, M Yilmaz, M Kocak, A Demirel, O Ucuncu, HO Ersoz Journal of endocrinological investigation 32, 169-174, 2009 | 114 | 2009 |
| Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy K Ukinc, HO Ersoz, C Karahan, C Erem, S Eminagaoglu, ... Endocrine 36, 255-261, 2009 | 112 | 2009 |
| Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma C Erem, M Kocak, İ Nuhoglu, M Yılmaz, O Ucuncu Clinical endocrinology 73 (4), 502-507, 2010 | 101 | 2010 |
| Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome C Erem, N Kandemir, A Hacihasanoglu, H Önder Ersöz, K Ukinc, M Kocak Endocrine 25, 55-60, 2004 | 91 | 2004 |
| A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin K Ukinc, S Eminagaoglu, HO Ersoz, C Erem, C Karahan, ... Endocrine 36, 425-432, 2009 | 85 | 2009 |
| Tip 2 Diyabetes Mellituslu Hastalarda Yaşam Kalitesi ve Ruhsal Belirtiler. İ Özdemir, Ç Hocaoğlu, M Koçak, HÖ Ersöz Dusunen Adam: Journal of Psychiatry & Neurological Sciences 24 (2), 2011 | 66 | 2011 |
| Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing’s Syndrome M Baykan, C Erem, Ö Gedikli, A Hacihasanoglu, T Erdogan, M Kocak, ... Endocrine 31, 300-304, 2007 | 56 | 2007 |
| Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism C Erem, O Ucuncu, M Yilmaz, M Kocak, İ Nuhoglu, HO Ersoz Endocrine 35, 75-80, 2009 | 51 | 2009 |
| Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's Syndrome M Baykan, C Erem, Ö Gedikli, A Hacihasanoglu, T Erdogan, M Kocak, ... Echocardiography 25 (2), 182-190, 2008 | 49 | 2008 |
| Adrenal ganglioneuroma: report of a new case C Erem, O Ucuncu, I Nuhoglu, A Cinel, U Cobanoglu, A Demirel, E Koc, ... Endocrine 35, 293-296, 2009 | 48 | 2009 |
| Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels C Erem, M Kocak, A Hacihasanoglu, M Yilmaz, F Saglam, HO Ersoz Experimental and clinical endocrinology & diabetes 116 (10), 619-624, 2008 | 48 | 2008 |
| Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an … C Erem, İ Nuhoglu, M Kocak, M Yilmaz, ST Sipahi, O Ucuncu, HO Ersoz Endocrine 33, 270-276, 2008 | 46 | 2008 |
| Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with … C Erem, M Kocak, I Nuhoglu, M Yilmaz, O Ucuncu European Journal of Endocrinology 160 (5), 863-868, 2009 | 37 | 2009 |
| Current prevalence of goiter determined by ultrasonography and associated risk factors in a formerly iodine-deficient area of Turkey M Kocak, C Erem, O Deger, M Topbas, HO Ersoz, E Can Endocrine 47, 290-298, 2014 | 33 | 2014 |
| Dopamine-secreting adrenal ganglioneuroma presenting with paroxysmal hypertension attacks C Erem, M Kocak, A Cinel, HO Ersoz, A Reis Saudi medical journal 29 (1), 122, 2008 | 33 | 2008 |
| Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism C Erem, O Ucuncu, M Yilmaz, M Kocak, İ Nuhoglu, HO Ersoz Endocrine 36, 473-478, 2009 | 30 | 2009 |
| Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly M Baykan, C Erem, Ö Gedikli, A Hacıhasanoglu, T Erdogan, M Kocak, ... Medical Principles and Practice 18 (3), 228-232, 2009 | 29 | 2009 |
